ResearcherConsejo Nacional de Investigaciones Científicas y TécnicasActive in the last 2 years
Ana Sahores
Matched on ORCID iD 0000-0001-5439-2677; OpenAlex author ID A5069060902. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 21
2019: 1 paper · 2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper · 2024: 2 papers · 2025: none · 2026: 1 paper
Papers 6
- Stage-resolved gene drivers of pancreatic ductal adenocarcinoma progression and therapeutic vulnerabilities. Co-author DOI 10.1016/j.isci.2026.115164↗
- Flurbiprofen inhibits cAMP transport by MRP4/ABCC4 increasing the potency of gemcitabine treatment in PDAC cell models. Co-author DOI 10.1016/j.ijbiomac.2024.136386↗
- The xenobiotic transporter ABCC4/MRP4 promotes epithelial mesenchymal transition in pancreatic cancer. First author DOI 10.3389/fphar.2024.1432851↗
- [The mRNA vaccine for the treatment of pancreatic cancer is here to stay]. Co-author PMID 37582144↗
- Multidrug transporter MRP4/ABCC4 as a key determinant of pancreatic cancer aggressiveness. Co-author DOI 10.1038/s41598-020-71181-w↗
- Identification of MRP4/ABCC4 as a Target for Reducing the Proliferation of Pancreatic Ductal Adenocarcinoma Cells by Modulating the cAMP Efflux. Co-author DOI 10.1124/mol.118.115444↗
Closest collaborators
The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Agustín Yaneff · 6 shared papers, 2019–2026 · strength 0.95
- Paper Flurbiprofen inhibits cAMP transport by MRP4/ABCC4 increasing the potency of gemcitabine treatment in PDAC cell models. DOI 10.1016/j.ijbiomac.2024.136386↗
- Paper Stage-resolved gene drivers of pancreatic ductal adenocarcinoma progression and therapeutic vulnerabilities. DOI 10.1016/j.isci.2026.115164↗
- Paper The xenobiotic transporter ABCC4/MRP4 promotes epithelial mesenchymal transition in pancreatic cancer. DOI 10.3389/fphar.2024.1432851↗
- Carlos Alberto Davio · 5 shared papers, 2019–2024 · strength 0.75
- Paper Flurbiprofen inhibits cAMP transport by MRP4/ABCC4 increasing the potency of gemcitabine treatment in PDAC cell models. DOI 10.1016/j.ijbiomac.2024.136386↗
- Paper The xenobiotic transporter ABCC4/MRP4 promotes epithelial mesenchymal transition in pancreatic cancer. DOI 10.3389/fphar.2024.1432851↗
- Paper [The mRNA vaccine for the treatment of pancreatic cancer is here to stay]. PMID 37582144↗
- Betina González · 3 shared papers, 2023–2024 · strength 0.56
- Paper Flurbiprofen inhibits cAMP transport by MRP4/ABCC4 increasing the potency of gemcitabine treatment in PDAC cell models. DOI 10.1016/j.ijbiomac.2024.136386↗
- Paper The xenobiotic transporter ABCC4/MRP4 promotes epithelial mesenchymal transition in pancreatic cancer. DOI 10.3389/fphar.2024.1432851↗
- Paper [The mRNA vaccine for the treatment of pancreatic cancer is here to stay]. PMID 37582144↗
- Nicolas Alejandro Fraunhoffer · 3 shared papers, 2023–2026 · strength 0.54
- Paper Stage-resolved gene drivers of pancreatic ductal adenocarcinoma progression and therapeutic vulnerabilities. DOI 10.1016/j.isci.2026.115164↗
- Paper The xenobiotic transporter ABCC4/MRP4 promotes epithelial mesenchymal transition in pancreatic cancer. DOI 10.3389/fphar.2024.1432851↗
- Paper [The mRNA vaccine for the treatment of pancreatic cancer is here to stay]. PMID 37582144↗
- Juan Iovanna · 3 shared papers, 2023–2026 · strength 0.54
- Paper Stage-resolved gene drivers of pancreatic ductal adenocarcinoma progression and therapeutic vulnerabilities. DOI 10.1016/j.isci.2026.115164↗
- Paper The xenobiotic transporter ABCC4/MRP4 promotes epithelial mesenchymal transition in pancreatic cancer. DOI 10.3389/fphar.2024.1432851↗
- Paper [The mRNA vaccine for the treatment of pancreatic cancer is here to stay]. PMID 37582144↗
- Nelson Dusetti · 3 shared papers, 2023–2026 · strength 0.54
- Paper Stage-resolved gene drivers of pancreatic ductal adenocarcinoma progression and therapeutic vulnerabilities. DOI 10.1016/j.isci.2026.115164↗
- Paper The xenobiotic transporter ABCC4/MRP4 promotes epithelial mesenchymal transition in pancreatic cancer. DOI 10.3389/fphar.2024.1432851↗
- Paper [The mRNA vaccine for the treatment of pancreatic cancer is here to stay]. PMID 37582144↗
- Oscar Mazza · 2 shared papers, 2023–2026 · strength 0.35
- María Eugenia Pasqualini · 2 shared papers, 2023–2026 · strength 0.35
- María Noé Garcia · 2 shared papers, 2023–2026 · strength 0.35
- Eduardo Chuluyán · 2 shared papers, 2023–2026 · strength 0.35
- Daniela Laura Papademetrio · 2 shared papers, 2023–2026 · strength 0.35
- Daniel Grasso · 2 shared papers, 2023–2026 · strength 0.35
- Ramiro Héctor Cerviño · 1 shared paper, 2024 · strength 0.23
- Analía Meilerman Abuelafia · 1 shared paper, 2026 · strength 0.21
- Jonathan Garnier · 1 shared paper, 2026 · strength 0.21
- Brice Chanez · 1 shared paper, 2026 · strength 0.21
- Pascal R. Hammel · 1 shared paper, 2026 · strength 0.21
- Samanta N. Gancedo · 1 shared paper, 2024 · strength 0.19
- Alejandro Carozzo · 2 shared papers, 2019–2020 · strength 0.19
- Patricia Santofimia‐Castaño · 1 shared paper, 2023 · strength 0.14
- Natalia Fernández · 1 shared paper, 2019 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.